Package 70710-1726-8

{"route": ["INTRAVENOUS"], "spl_id": "b3627acf-0207-443a-8e5a-0b4ad974715a", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0370710172619"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["e425731e-626b-4141-a997-fb85e077c2a4"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-1)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70710-1726-1", "marketing_start_date": "20211117"}, {"sample": false, "description": "6 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-8)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70710-1726-8", "marketing_start_date": "20211117"}], "brand_name": "Nelarabine", "product_id": "70710-1726_b3627acf-0207-443a-8e5a-0b4ad974715a", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "70710-1726", "generic_name": "Nelarabine", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nelarabine", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA215037", "marketing_category": "ANDA", "marketing_start_date": "20211117", "listing_expiration_date": "20261231"}